REVVITY, INC Deferred Tax Liabilities, Unrealized Currency Transaction Gains
REVVITY, INC (RVTY) had Deferred Tax Liabilities, Unrealized Currency Transaction Gains of $43.89 million as of 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains · last filed 2026-02-24
- 2025-12-28: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $43.89M.
- 2024-12-29: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $0.00.
- 2017-12-31: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $0.00.
- 2017-01-01: Deferred Tax Liabilities, Unrealized Currency Transaction Gains $15.73M.
| Period end | Deferred Tax Liabilities, Unrealized Currency Transaction Gains |
|---|---|
| 2025-12-28 | $43.89M 10-K · filed 2026-02-24 |
| 2024-12-29 | $0.00 10-K · filed 2026-02-24 |
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2017-01-01 | $15.73M 10-K · filed 2018-02-27 |
| 2016-01-03 | $782.00K 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |